Presseportal: Abbott Laboratories - Abbott meldet Aufhebung des ...
05.08.08 21:26 Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily 06:02 New Abbott Aluvia(R) Tablet for Treatment of HIV Available in South Africa
chemie.pr-rss.com
03.06.2008 06:40:05
Abbott Laboratories: Johannesburg, South Africa (ots/PRNewswire) - - More than 5 Million South Africans Living with HIV Gain Access to First and Only Co-formulated, Non-refrigerated Protease Inhibitor Abbott (NYSE: ABT) today announced that the new tablet ...
Lesen Sie hier weiter... |
Drucken |
PDF
05.08.08 21:26 Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily 06:02 New Abbott Aluvia(R) Tablet for Treatment of HIV Available in South Africa
MedCrawler.de - Die Suchmaschine für Medizin und Gesundheit - indiziert auschliesslich deutschsprachige Seiten mit New Abbott Aluvia(R) Tablet for
New Abbott Aluvia(R) Tablet for Treatment of HIV Available in South Africa = 03.06.2008 / 06:04 New Abbott Kaletra(R) (lopinavir/ritonavir) Lower-Strength
New Abbott Aluvia(R) Tablet for Treatment of HIV Available in South Africa that the new tablet formulation of its protease inhibitor Aluvia(R) (lopinavir
New Abbott Aluvia(R) Tablet for Treatment of HIV Available in South Africa New Abbott Kaletra(R) (lopinavir/ritonavir) Lower-Strength Tablet for Pediatric